Pharmacogenomics Testing

By having access to your genetic data, your doctor eliminates a ‘one size fits all’ mentality and will develop a personal treatment plan that’s relevant for you and you only.

Pharmacogenomics covers 3 topics:

• Whether a medication may be an effective treatment for you
• What is the best dose of a medication for you
• Whether you could have serious side effects from a medication

Only you and your doctor will see the results as they are confidential.

Once your doctor has seen and analysed your test results, he or she will know precisely what to prescribe and at what dose. The beauty of having this test done is that since your genetic makeup doesn’t change with age, the results remain relevant and they can be used whenever you require prescription medicine.

Testing is recommended for anyone, regardless of age, who is or who may be about to receive prescribed medications with indicated pharmacogenomic biomarkers. In particular:

• when there is more than one drug to choose from
• patients taking drugs with high incidence or serious side effects
• when the starting dosage is not clear
• patients who are taking more than one drug

PGxOne™ Plus is a pharmacogenetic test that comprehensively assays 50 well-established pharmacogenomic genes and detects ~200 variants and CNVs (Copy Number Variants) in a single, cost-effective test.

Clinical specialities include:
Cardiology • Psychiatry • Pain Management • Oncology • Infectious Disease • AIM • Endocrinology • Neurology • Rheumatology • Gastroenterology • Immunology • Urology

Advanced next-generation sequencing technology allows us, for the first time, to give blanket coverage to variants in 50 genes and the results are delivered quickly.

You will be provided with an easy-to-read, clinically relevant and medically actionable report which you can go through with your patient.

PGxOne™ Plus sequencing data (variant detection) has been validated by direct comparison to data generated by Sanger sequencing, considered the gold-standard DNA sequencing technique by the world’s largest life sciences laboratories. The PGxOne™ Plus test displayed 100% sensitivity (true positive detection rate) and 100% specificity (true negative detection rate).